| 1 | Case Studies 2021-07-09 |
Play |
| 2 | Treatment Strategies & Options 2021-07-09 |
Play |
| 3 | Recognition & Diagnosis 2021-07-09 |
Play |
| 4 | Pathogenesis & Clinical Features 2021-07-09 |
Play |
Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease
Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.
